Viewing nowDapagliflozin Tablet 10 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.

MFDS item code 202201016 · Approved 2022.03.11 · Insurance code 648508060
Improves blood glucose control in type 2 diabetes mellitus; prevents worsening of chronic heart failure and chronic kidney disease
This medication helps control blood sugar levels in patients with type 2 diabetes and reduces the risk of cardiovascular diseases in patients with chronic heart failure, as well as lowering the risk of decline in kidney function and related mortality in patients with chronic kidney disease. It is also beneficial for patients with type 2 diabetes who have cardiovascular diseases or risk factors and is administered in conjunction with standard medications for each condition. Therefore, this medication is effective for improving blood sugar control and cardiovascular and kidney health.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this drug is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this drug is not recommended in patients with chronic heart failure or chronic kidney disease. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in certain patients. It is contraindicated in patients with allergies to the main ingredient or excipients, type 1 diabetes, diabetic ketoacidosis, and patients with lactose intolerance or related genetic disorders. Moreover, it should not be used in patients undergoing dialysis. Caution is advised when administering to patients with reduced fluid volume or renal impairment. This medication can lower blood pressure or reduce intravascular fluid volume, posing a risk of symptomatic hypotension or acute kidney injury. In particular, patients with diminished renal function, elderly patients, and those on diuretics should be closely monitored for fluid status and renal function before and after administration. Adverse effects of this medication may occur. The most common side effect is genital infections, which occur more frequently in females and those with a history of infections. Other reported side effects include hypoglycemia, fluid volume depletion, dizziness, dry mouth, urinary tract infections, and dysuria. Increased serum creatinine associated with renal function should also be monitored. This medication can cause a serious metabolic acidosis known as ketoacidosis. Ketoacidosis may occur even if blood sugar levels are not high, so if symptoms such as nausea, vomiting, abdominal pain, lethargy, or dyspnea arise, medical consultation should be sought immediately. The risk of serious urinary infections such as urinary tract infections and pyelonephritis may increase, so prompt treatment is necessary if infection symptoms occur. Elderly patients or those with reduced renal function are particularly at higher risk for fluid volume depletion and hypotension. The risk of hypoglycemia may increase when this medication is used with insulin or sulfonylureas, so dose adjustments for these medications may be necessary. Pregnant or breastfeeding women are advised not to use this medication and should discontinue use if pregnancy is confirmed. There is no specific antidote for overdose; however, appropriate treatment should be provided based on the patient's condition, and it is unknown whether this medication is removed by dialysis. When taking this medication, it does not significantly affect driving or machinery operation, but caution is advised in cases where there is a risk of hypoglycemia. Lastly, the safety and efficacy of this medication in children have not been established, and it is important to keep it out of the reach of children and store it in its original container.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decrease in fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased creatinine clearance in the early stage of treatment, dyslipidemia, increased serum creatinine in the early stage of treatment, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral arterial occlusion, angina pectoris, myocardial infarction, biliary calculi, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory disturbance, cerebral infarction, nerve compression, sensory loss, headache, fatigue, hunger, pruritus, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus, acute pancreatitis, chronic pancreatitis, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, sequelae, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorder, syncope, tremor, nasopharyngitis, upper respiratory tract infection, edema, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like syndrome, vaginal discharge, menstrual irregularities, hair loss, dermatitis, xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating abnormal eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteoporosis, contusion, road traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, pelvic fracture, laceration, ligament rupture, limb injury, meniscal injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibia fracture, dental injury, dry eye, ocular pain, retinal disorder, vision impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, speech disturbance, epistaxis, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, angina pectoris, atrial fibrillation, diastolic dysfunction, anxiety disorder, nocturia, auditory hallucinations, suicide attempt, biliary polyp, liver cyst, dizziness, adenoma, neurofibroma, unspecified pituitary neoplasm, male gonadal deficiency, thyroid cyst, thyroid nodule, food allergy, erythrocytosis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.
Yellow, bi-convex, diamond-shaped film-coated tablets
28 tablets/box (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.